SCHEMBL312744

SCHEMBL312744

C[C@H]1CCN[C@@H]1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4588183 1.00
SCHEMBL882973 1.00
SCHEMBL2034574 1.00
SCHEMBL5207176 1.00
SCHEMBL312745 1.00
SCHEMBL6079315 1.00
SCHEMBL2182805 1.00
SCHEMBL312743 1.00
SCHEMBL7558402 0.98 SLC1A2 (0.56)
SCHEMBL7558398 0.98 SLC1A2 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2190 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11203622-B2 MASP isoforms as inhibitors of complement activation OMEROS CORPORATION (US) 2021-12-21 US claimed
EP-2688578-B1 MIA (MELANOMA INHIBITORY ACTIVITY) INHIBITORS FOR PREVENTING AND CURING VITILIGO BORDIGNON MATTEO (IT) 2019-03-27 EP claimed
CN-103930122-A MIA (melanoma inhibitory activity protein) inhibitor for detecting, preventing and treating leukoderma BORDIGNON MATTEO 2014-07-16 CN claimed
US-20140155371-A1 MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE BASF SE (DE) 2014-06-05 US claimed
EP-2688578-A2 MIA (MELANOMA INHIBITORY ACTIVITY) INHIBITORS FOR DETECTING, PREVENTING AND CURING VITILIGO Bordignon, Matteo (IT) 2014-01-29 EP claimed
US-20140004130-A1 MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo BORDIGNON MATTEO (IT) 2014-01-02 US claimed
WO-2013014604-A1 MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE BASF SE (DE) 2013-01-31 WO claimed
WO-2012127352-A2 MIA (MELANOMA INHIBITORY ACTIVITY) INHIBITORS FOR DETECTING, PREVENTING AND CURING VITILIGO BORDIGNON MATTEO (IT) 2012-09-27 WO claimed
US-20120208774-A1 METHOD FOR INHIBITING \"MELANOMA INHIBITORY ACTIVITY\" MIA ANTISENSE PHARMA GMBH (DE) 2012-08-16 US claimed
US-8148493-B2 Method for inhibiting “melanoma inhibitory activity” MIA ANTISENSE PHARMA GMBH (DE) 2012-04-03 US claimed
US-20100273705-A1 Method for inhibiting \"Melanoma Inhibitory Activity\" MIA ANTISENSE PHARMA GMBH. 2010-10-28 US claimed
US-20090148921-A1 Compositions and methods for enhancing apoptosis GENENTECH, INC. (US) 2009-06-11 US claimed
EP-1590666-B1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH INC (US) 2008-07-09 EP claimed
US-20060128607-A1 Method for inhibiting \"melanoma inhibitory activity\" mia ANTISENSE PHARMA GMBH (DE) 2006-06-15 US claimed
EP-1472279-A1 A METHOD FOR INHIBITING \"MELANOMA INHIBITORY ACTIVITY\" MIA Antisense Pharma GmbH (DE) 2004-11-03 EP claimed
US-20040171554-A1 Compositions and methods for enhancing apoptosis GENENTECH, INC. 2004-09-02 US claimed
WO-2003064457-A1 A METHOD FOR INHIBITING 'MELANOMA INHIBITORY ACTIVITY' MIA ANTISENSE PHARMA GMBH (DE) 2003-08-07 WO claimed
US-20260146104-A1 ANTIBODIES, ACTIVATABLE ANTIBODIES, BISPECIFIC ANTIBODIES, AND BISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF CYTOMX THERAPEUTICS, INC. (US) 2026-05-28 US disclosed
EP-0001845-A2 Analeptic tripeptides, process for their preparation and pharmaceutical composition containing the same MERCK & CO. INC. (US) 1979-05-16 EP disclosed
US-4030994-A FLUOROXY PENTAFLUOROSULFUR MERCK & CO., INC. (US) 1977-06-21 US disclosed